Allogene Therapeutics, Inc. Common Stock
$2.190
USD
Last updated on --.
24h volume9.41M
24h highest2.2450 USD
24h lowest2.0450 USD
24h Price movement+0.92%
ALLO recent prices
24 Hours
+0.92%+$0.02
30 days
+1.86%+$0.04
60 days
-11.69%-$0.29
90 days
-13.44%-$0.34
Key data
Previous close2.1700 USD
Market cap748.99M USD
Volume9.41M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.50000 USD
Net income (FY)-173.76M USD
Revenue (FY)--
Last report dateMay 13, 2026
About Allogene Therapeutics, Inc. Common Stock
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)152.00
Net income per employee (FY)-1.14M USD
Listed onNasdaq
ALLO conversion tables
 |  |
|---|---|
| 0.5 ALLO | 1.095 USD |
| 1 ALLO | 2.190 USD |
| 5 ALLO | 10.95 USD |
| 10 ALLO | 21.9 USD |
| |
|---|---|
| 0.5 USD | 0.22831 ALLO |
| 1 USD | 0.45662 ALLO |
| 5 USD | 2.283 ALLO |
| 10 USD | 4.566 ALLO |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ALLO is trading at $2.190, +0.92% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ALLO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ALLO is currently trading at $2.190, +0.92% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ALLO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ALLO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ALLO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ALLO's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Allogene Therapeutics, Inc. Common Stock's market cap is currently 748.99M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume9.41M
24h highest2.2450 USD
24h lowest2.0450 USD
24h Price movement+0.92%
Start trade with ALLO Perpetual
Sign up to trade